ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 251 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,816,000 | -10.1% | 320,736 | -13.6% | 0.00% | 0.0% |
| Q4 2020 | $5,359,000 | +79.9% | 371,108 | +1.4% | 0.00% | +33.3% |
| Q3 2020 | $2,979,000 | +19.3% | 365,965 | -0.8% | 0.00% | +50.0% |
| Q2 2020 | $2,497,000 | -1.6% | 368,767 | +2.3% | 0.00% | -33.3% |
| Q1 2020 | $2,537,000 | -49.1% | 360,398 | -29.0% | 0.00% | -40.0% |
| Q4 2019 | $4,982,000 | +41.1% | 507,622 | +57.9% | 0.01% | +25.0% |
| Q3 2019 | $3,530,000 | +17.3% | 321,498 | +24.2% | 0.00% | 0.0% |
| Q2 2019 | $3,009,000 | -9.7% | 258,766 | -25.9% | 0.00% | 0.0% |
| Q1 2019 | $3,332,000 | -8.8% | 349,266 | -7.9% | 0.00% | -20.0% |
| Q4 2018 | $3,655,000 | -36.5% | 379,192 | -6.1% | 0.01% | -28.6% |
| Q3 2018 | $5,754,000 | +7.5% | 403,778 | -9.5% | 0.01% | 0.0% |
| Q2 2018 | $5,354,000 | -11.5% | 446,147 | -8.9% | 0.01% | -22.2% |
| Q1 2018 | $6,050,000 | -19.8% | 489,885 | -5.6% | 0.01% | -10.0% |
| Q4 2017 | $7,547,000 | +4.8% | 518,727 | +2.5% | 0.01% | -9.1% |
| Q3 2017 | $7,201,000 | +17.8% | 506,028 | +5.6% | 0.01% | +10.0% |
| Q2 2017 | $6,113,000 | -0.2% | 479,100 | -0.8% | 0.01% | 0.0% |
| Q1 2017 | $6,127,000 | +24.3% | 483,200 | +0.1% | 0.01% | +25.0% |
| Q4 2016 | $4,930,000 | -33.0% | 482,900 | -13.6% | 0.01% | -33.3% |
| Q3 2016 | $7,358,000 | -5.0% | 558,700 | -8.4% | 0.01% | -7.7% |
| Q2 2016 | $7,743,000 | -3.7% | 609,700 | +0.2% | 0.01% | 0.0% |
| Q1 2016 | $8,037,000 | -6.8% | 608,400 | +8.5% | 0.01% | -7.1% |
| Q4 2015 | $8,624,000 | +31.8% | 560,700 | +6.3% | 0.01% | +27.3% |
| Q3 2015 | $6,541,000 | +12.8% | 527,500 | +24.4% | 0.01% | +22.2% |
| Q2 2015 | $5,799,000 | +943.0% | 423,900 | +1055.0% | 0.01% | +800.0% |
| Q4 2013 | $556,000 | -88.8% | 36,700 | -89.0% | 0.00% | -88.9% |
| Q3 2013 | $4,963,000 | +39.8% | 333,728 | +21.7% | 0.01% | +28.6% |
| Q2 2013 | $3,550,000 | – | 274,328 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |